IGEM Therapeutics Shortlisted as a Finalist in the “Best Start-up Biotech Company” Category of the 2018 OBN Awards
August 22, 2018
London, 22 August 2018 – IGEM Therapeutics (IGEM), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer, today announced that it has